Clinical trial
A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and…
NCT00097578 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00097578 |
|---|---|
| Title | A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma |
| Official title | An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Adenocarcinoma |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Colorectal Cancer |
| Enrollment | 1,953 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Nov 25, 2004 |
| Last update posted | Mar 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: